186 related articles for article (PubMed ID: 22228071)
1. Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma.
Schlecht NF; Brandwein-Gensler M; Smith RV; Kawachi N; Broughel D; Lin J; Keller CE; Reynolds PA; Gunn-Moore FJ; Harris T; Childs G; Belbin TJ; Prystowsky MB
Head Neck Pathol; 2012 Jun; 6(2):232-43. PubMed ID: 22228071
[TBL] [Abstract][Full Text] [Related]
2. Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma.
Madan R; Brandwein-Gensler M; Schlecht NF; Elias K; Gorbovitsky E; Belbin TJ; Mahmood R; Breining D; Qian H; Childs G; Locker J; Smith R; Haigentz M; Gunn-Moore F; Prystowsky MB
Head Neck; 2006 Nov; 28(11):1018-27. PubMed ID: 16783828
[TBL] [Abstract][Full Text] [Related]
3. Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Aigelsreiter AM; Aigelsreiter A; Wehrschuetz M; Ress AL; Koller K; Salzwimmer M; Gerger A; Schauer S; Bauernhofer T; Pichler M
Hum Pathol; 2014 Apr; 45(4):683-90. PubMed ID: 24565202
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
5. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma.
Abdou AG; Sakr S; Elwahed MM; Eladly EK
Ultrastruct Pathol; 2016; 40(4):181-8. PubMed ID: 27042764
[TBL] [Abstract][Full Text] [Related]
7. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
8. Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients.
Wong MP; Cheang M; Yorida E; Coldman A; Gilks CB; Huntsman D; Berean K
Pathology; 2008 Oct; 40(6):611-6. PubMed ID: 18752129
[TBL] [Abstract][Full Text] [Related]
9. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
[TBL] [Abstract][Full Text] [Related]
10. Expression of ezrin and moesin related to invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Wang X; Liu M; Zhao CY
Genet Mol Res; 2014 Sep; 13(3):8002-13. PubMed ID: 25299115
[TBL] [Abstract][Full Text] [Related]
11. Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy.
Mhawech-Fauceglia P; Dulguerov P; Beck A; Bonet M; Allal AS
J Clin Pathol; 2007 Feb; 60(2):185-9. PubMed ID: 16698950
[TBL] [Abstract][Full Text] [Related]
12. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical negative expression of ezrin predicts poor prognosis in clear cell renal cell carcinoma.
Ferrari MVO; da Costa WH; Matushita MAM; Meduna RR; Brazao ES; Bezerra SM; da Cunha IW; Zequi SC
Urol Oncol; 2020 Mar; 38(3):75.e1-75.e7. PubMed ID: 31648868
[TBL] [Abstract][Full Text] [Related]
14. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
[TBL] [Abstract][Full Text] [Related]
15. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
[TBL] [Abstract][Full Text] [Related]
16. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
17. Expression of ezrin in oral squamous cell carcinoma: Prognostic impact and clinicopathological correlations.
Safi AF; Nickenig HJ; Rothamel D; Zirk M; Thiele O; Grandoch A; Scheer M; Zinser M; Zöller J; Drebber U; Kreppel M
J Craniomaxillofac Surg; 2015 Nov; 43(9):1899-905. PubMed ID: 26447027
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
20. Connexin 43 (Cx43) Expression in Laryngeal Squamous Cell Carcinomas: Preliminary Data on Its Possible Prognostic Role.
Puzzo L; Caltabiano R; Parenti R; Trapasso S; Allegra E
Head Neck Pathol; 2016 Sep; 10(3):292-7. PubMed ID: 26748803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
